Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II

被引:100
作者
Fleischhack, G [1 ]
Kambeck, I [1 ]
Cipic, D [1 ]
Hasan, C [1 ]
Bode, U [1 ]
机构
[1] Univ Bonn, Dept Paediat Haematol Oncol, D-5300 Bonn, Germany
关键词
procalcitonin; CRP; febrile neutropenia; inflammatory cytokines; inflammatory soluble cytokine receptors;
D O I
10.1046/j.1365-2141.2000.02458.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sensitive parameters of inflammation are rare in neutropenic cancer patients. In this study, procalcitonin (PCT), C-reactive protein (CRP), interleukin 6 (IL-6), IL-8, the soluble IL-2 receptor (sIL-2R) and the soluble tumour necrosis factor receptor II (sTNFRII) were evaluated for their diagnostic relevance in febrile episodes of cancer patients, Plasma or serum levels of these parameters were determined in neutropenic children with febrile episodes (n = 122) classified according to both the kind of infection [60 cases of fever of unknown origin (FUO), 28 cases of localized infection, 13 cases of pneumonia, 20 cases of bacteraemia, one case of fungaemia] and the World Health Organization (WHO) score of chemotherapy-induced mucositis, Rt baseline and during the febrile episodes, the highest levels of all parameters were observed in cases of gram-negative bacteraemia. However, in FUO and localized infections, low or only slightly elevated median levels of all parameters were documented, The degree of chemotherapy-induced mucositis did not influence the value of any parameter. In comparison with the other inflammatory parameters, PCT (optimum cut-off level 0.5 mug/l) was a more sensitive and more specific parameter in the diagnosis of high-risk (gram-negative bacteraemia)and low-risk (FUO) episodes, as well as in the sequential assessment of all febrile neutropenic episodes.
引用
收藏
页码:1093 / 1102
页数:10
相关论文
共 48 条
[1]  
Al-Nawas B, 1996, Eur J Med Res, V1, P331
[2]   Procalcitonin in patients with and without immunosuppression and sepsis [J].
AlNawas, B ;
Shah, PM .
INFECTION, 1996, 24 (06) :434-436
[3]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[4]   INTERLEUKIN-8, A CHEMOTACTIC AND INFLAMMATORY CYTOKINE [J].
BAGGIOLINI, M ;
CLARKLEWIS, I .
FEBS LETTERS, 1992, 307 (01) :97-101
[5]   INTERLEUKIN-6 AND ITS RECEPTOR DURING HOMEOSTASIS, INFLAMMATION, AND TUMOR-GROWTH [J].
BAUER, J .
KLINISCHE WOCHENSCHRIFT, 1989, 67 (14) :697-706
[6]   Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis [J].
Beaune, G ;
Bienvenu, F ;
Pondarré, C ;
Monneret, G ;
Bienvenu, J ;
Souillet, G .
INFECTION, 1998, 26 (03) :168-169
[7]   Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults [J].
Bernard, L ;
Ferrière, F ;
Casassus, P ;
Malas, F ;
Lévêque, S ;
Guillevin, L ;
Lortholary, O .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) :914-915
[8]  
Bodey B, 1996, ANTICANCER RES, V16, P219
[9]   Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells [J].
Carter, A ;
Haddad, N ;
Draxler, I ;
Israeli, E ;
Raz, B ;
Rowe, JM .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 92 (01) :116-126
[10]   Procalcitonin in pediatrics: Overview and challenge [J].
Chiesa, C ;
Pacifico, L ;
Mancuso, G ;
Panero, A .
INFECTION, 1998, 26 (04) :236-241